Clinical Trial Update: 18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating 18F-Fluoroazomycin Arabinoside PET-CT for diagnosing solid tumors, including breast and colorectal cancers, with active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Pancreatic Cancer
• Solid Tumors

Drugs mentioned

• 18F-Fluoroazomycin Arabinoside (18F-Fluoroazomycin Arabinoside)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Malignant Breast Neoplasm, Malignant Colorectal Neoplasm | Phase 1 | Status: ACTIVE_NOT_RECRUITING